Thursday, November 1, 2012
Yale School of Medicine
researchers have mouse data showing that vaginal application of two chemokines
recruits memory T cells into vaginal tissue and improves the protective effect
of an HSV-2 vaccine.1 The team is now working to prolong the
duration of the chemokines' effects and wants to extend the strategy to HIV
Haas, M.J. SciBX 5(43); doi:10.1038/scibx.2012.1130
Published online Nov. 1, 2012
1. Shin, H. & Iwasaki,
A. Nature; published online Oct. 17, 2012; doi:10.1038/nature11522
Contact: Akiko Iwasaki, Yale School of Medicine, New Haven, Conn.
2. Nakanishi, Y. et al.
Nature 462, 510-513 (2009)
AND INSTITUTIONS MENTIONED
(NYSE:MMM), St. Paul, Minn.
Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind.
Genocea Biosciences Inc., Cambridge, Mass.
GenVec Inc. (NASDAQ:GNVC), Gaithersburg, Md.
(SSE:MEDAA), Solna, Sweden
Medicis Pharmaceutical Corp. (NYSE:MRX), Scottsdale, Ariz.
Yale School of Medicine, New Haven, Conn.
Yale University, New Haven, Conn.